14 pages matching M&As in this book
Results 1-3 of 14
What people are saying - Write a review
We haven't found any reviews in the usual places.
Global Industry Perspective
Commemorative Poster 15
11 other sections not shown
acquisition Amgen antibodies aptamers Asia-Pacific Asian avian flu big pharma biofuels Biogen Idec biologics biotech companies biotech industry biotech sector biotechnology biotechnology companies biotechnology industry boost Canada Canadian cancer challenges China Chinese clinical trials commercialization compa competitive costs deals diagnostic diseases drug development early-stage emerging equity Ernst & Young Europe European biotech financing firms focus focused funding gene Genentech genetic Genomics Germany GlaxoSmithKline Global Biotechnology growth increased India industry's initial public offerings innovative investment investors IPOs late-stage launched M&As manufacturing market cap market capitalization medicine ment mergers million molecular nies nology Novartis panies partners patent percent performance Pharmaceuticals Phase pipeline potential prod product approvals programs proteins public companies Qiagen recent regulatory revenues rounds segment SFDA significant Source startup stem cell strategic alliances strong success Switzerland targeted tech therapeutics therapies tion trends ucts vaccines VentureOne Zeltia